Nrf1-dependent Proteotoxic Stress Response
Nrf1 依赖性蛋白毒性应激反应
基本信息
- 批准号:10584465
- 负责人:
- 金额:$ 32.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcetylationAntioxidantsAspartic EndopeptidasesAutophagocytosisAutophagosomeBasic ScienceBindingBiological AssayBiologyCancer cell lineCell NucleusCellsChemicalsClipCo-ImmunoprecipitationsCytosolDNA BindingDataEP300 geneEndoplasmic ReticulumEnsureErythroidFeedbackFoundationsGenesGeneticGenetic TranscriptionGleanHDAC1 geneHDAC2 geneHistone DeacetylaseHumanHuman PathologyKnowledgeLeadMalignant NeoplasmsMammalsMass Spectrum AnalysisMediatingMediatorMembraneMethodsMolecularMolecular ChaperonesMotionMutagenesisN-terminalNeurodegenerative DisordersNuclearNuclear ExtractNucleic Acid Regulatory SequencesOrganismOutputPathway interactionsPeptide HydrolasesPositioning AttributeProcessProteasome InhibitionProteasome InhibitorProteinsProteolytic ProcessingProteomicsPublishingRecoveryRegulationResponse ElementsRoleRouteShapesStressTestingTranscriptTranscriptional ActivationTransferaseTransmembrane DomainWorkYeastsattenuationbiological adaptation to stresscancer cellchromatin immunoprecipitationcofactorcopingexperienceexperimental studyhuman diseaseinhibitor therapyloss of functionmulticatalytic endopeptidase complexnovel strategiesp97 ATPasepolypeptidepromoterprotein degradationproteotoxicityresponsetherapeutic targettooltranscription factortranscriptome sequencingvalosin-containing protein
项目摘要
ABSTRACT
Proteotoxic stress or inhibition of cellular proteasome activity by proteasome
inhibitor drugs sets in motion an evolutionarily conserved pathway that directs the de
novo synthesis of proteasomes as a compensatory response. Our previous studies
established the transcription factor Nrf1 as a key player in this stress-response pathway.
Nrf1, by its ability to bind to the anti-oxidant response elements typically found in the
regulatory regions of proteasome genes, induces their expression in response to
proteasome inhibition. As an endoplasmic reticulum (ER)-bound transcription factor with
a bulk of its polypeptide in the lumen, Nrf1 activation involves its retrotranslocation into
the cytosol in a manner that depends on the ATPase p97/VCP. This is followed by
proteolytic processing and subsequent mobilization of the transcriptionally active form of
Nrf1 to the nucleus. Further understanding of the Nrf1 pathway could shed light on the
intricate mechanisms by which cells cope with proteotoxic stress.
In the first two aims, we propose to dissect the functional output and the
mechanism of activation of Nrf1 pathway and explore various factors that assist in
mobilizing this transcription factor from the lumen of the ER all the way to the nucleus.
Using the information gleaned from the above two aims and using genetic and chemical
tools, in the third aim, we propose to test if inhibition of Nrf1 pathway leads to increased
efficacy of proteasome inhibitor treatment in cancer cells. Thus, the proposed line of
work is important not only from a basic research stand-point of furthering Nrf1 biology; it
is also significant from a translational perspective as well, since it has the potential to
illuminate novel strategies to modulate the cellular protein clearance pathways in various
human diseases.
摘要
蛋白毒性应激或蛋白酶体对细胞蛋白酶体活性的抑制
抑制剂药物启动了一条进化上保守的途径,
作为补偿反应的蛋白酶体的重新合成。我们以前的研究
建立了转录因子Nrf 1作为一个关键球员在这一压力反应途径。
Nrf 1通过其与抗氧化反应元件结合的能力,该元件通常存在于
蛋白酶体基因的调节区,诱导它们的表达,
蛋白酶体抑制作为一种内质网(ER)结合的转录因子,
在管腔中的大量多肽中,Nrf 1的激活涉及其逆转位到
细胞质中的一种方式,依赖于ATP酶p97/VCP。这之后是
蛋白水解加工和随后的转录活性形式的动员
Nrf 1到细胞核。对Nrf 1通路的进一步了解可能有助于阐明
细胞科普蛋白毒性应激的复杂机制。
在前两个目标中,我们建议剖析功能输出和
Nrf 1通路的激活机制,并探讨各种因素,帮助
将这种转录因子从内质网腔一路转移到细胞核。
利用从上述两个目标中收集的信息,并使用遗传和化学方法,
工具,在第三个目标中,我们建议测试Nrf 1途径的抑制是否会导致增加
蛋白酶体抑制剂治疗在癌细胞中的功效。因此,拟议的路线
这项工作不仅从促进Nrf 1生物学的基础研究角度来看很重要,
从翻译的角度来看也很重要,因为它有可能
阐明新的战略,以调节细胞蛋白质清除途径,在各种
人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Senthil Kumar Radhakrishnan其他文献
Senthil Kumar Radhakrishnan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Senthil Kumar Radhakrishnan', 18)}}的其他基金
Analysis of Nrf1 pathway in Alzheimer's Disease
阿尔茨海默病 Nrf1 通路分析
- 批准号:
10288256 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Nrf1-dependent Proteotoxic Stress Response - Diversity Supplement
Nrf1 依赖性蛋白毒性应激反应 - 多样性补充剂
- 批准号:
10378935 - 财政年份:2019
- 资助金额:
$ 32.6万 - 项目类别:
Understanding and targeting Nrf1-mediated proteasome recovery pathway in cancer
了解和靶向癌症中 Nrf1 介导的蛋白酶体恢复途径
- 批准号:
8869297 - 财政年份:2014
- 资助金额:
$ 32.6万 - 项目类别:
Understanding and targeting Nrf1-mediated proteasome recovery pathway in cancer
了解和靶向癌症中 Nrf1 介导的蛋白酶体恢复途径
- 批准号:
9079410 - 财政年份:2014
- 资助金额:
$ 32.6万 - 项目类别:
Understanding and targeting Nrf1-mediated proteasome recovery pathway in cancer
了解和靶向癌症中 Nrf1 介导的蛋白酶体恢复途径
- 批准号:
8190333 - 财政年份:2011
- 资助金额:
$ 32.6万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 32.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 32.6万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 32.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 32.6万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 32.6万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 32.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




